Loading
Allergan Aesthetics, an AbbVie Company
Allergan Aesthetics, part of AbbVie, is a global business unit focused on medical aesthetics. Headquartered in Irvine, California, it was established in 2020 following AbbVie's acquisition of Allergan plc. The company employs between 1,001 and 5,000 people and serves customers in over 100 countries, generating more than $5.5 billion in revenue in 2024. The company offers a diverse portfolio of aesthetic products, including BOTOX® Cosmetic for facial treatments, the JUVÉDERM™ Collection of dermal fillers, COOLSCULPTING® for non-invasive body contouring, and Natrelle Breast Implants for surgical procedures. Allergan Aesthetics targets both consumers and medical professionals, providing innovative solutions and education to help individuals achieve their aesthetic goals. The company is recognized for its leadership in the injectables market and holds numerous regulatory approvals, ensuring compliance and safety in its offerings.
Funding
Every round, secondary, debt facility or acquisition involving Allergan Aesthetics, an AbbVie Company that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$4.9B